Close Menu

DSTL

A study of samples from Sierra Leone and the UK of heat-inactivated whole blood showed high sensitivity and specificity using the FilmArray BioThreat-E test.

Ploughshare Innovations, the technology-transfer outfit charged with commercializing discoveries made at the Defence Science and Technology Laboratory of the UK's Ministry of Defence, is seeking licensees for a one-step method for recovering trace amounts of DNA from tiny surface

Researchers from the UK's Defence Science and Technology Laboratory have demonstrated the feasibility of using Life Technologies' microfluidic TaqMan Array Cards to detect multiple bacterial agents with the potential to cause acute disease and be used in a bioterror attack.

Enigma said that the patents in question are no longer open to challenge by any entity. However, an official at Biogene who initiated the patent challenge said that the UK IPO's ruling was against him personally and doesn't preclude other entities such as Biogene from re-challenging the patents in question.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.